Novaerus Presents the Future of Infection Control with Defend 1050

By Sangeetha Swaroop, Contributing Editor

Participating at Arab Health for the fourth time this year, Novaerus, a leading Irish firm that specializes in the most effective technology for air dis-infection, continues on its mission to reduce indoor airborne pollutants by showcasing its latest product, Novaerus Defend 1050 (NV 1050), that combines rapid air dis-infection and purification to kill pathogens and trap particulates to control infection.

Globally, nosocomial infection is a serious and widespread problem with an estimated 1 in 10 patients acquiring an infection during a hospital stay. Airborne pathogens spread infection through inhalation and surface contamination. New research data points out that in Europe alone, healthcare acquired infections lead to 16 million additional days of hospital stay and 7 billion euros in direct costs.  

Athough all hospitals have air handling and air filtration systems, what makes Novaerus different, explains Kieran J. McBrien, Senior Vice-President, International Business Development, “is that our systems go above and beyond conventional systems to get into confined indoor spaces and add another level of air sterilisation and air cleaning. It works on two levels: one, it prevents direct transmission from person to person, and second, it also reduces contamination on surfaces by taking pathogens out of the air.”

“Every human is a bio bomb,” he adds. “We carry bacteria, we shed bacteria, and we pass on bacteria through contamination of surfaces and hands, thereby causing infection, allergies and irritation. Novaerus systems use ultra-low energy plasma technology that has been independently tested and proven to deactivate airborne bacteria and viruses, neutralise VOCs and reduce particulate such as mould spores, dust mites, pollen, etc.”

The newly launched Novaerus Defend 1050, he adds, “uses this unique patented plasma technology in combination with a triple-stage Camfil filter system – a leading Swedish manufacturer of premium clean air solutions – to give a powerful, compact and manoeuvrable air sterilisation device that provides an effective solution for both air dis-infection and particle removal.”

Designed for rapid remediation in large spaces and situations with high risk of infection, what makes Novaerus Defend 1050 superior is that “it offers much higher air volumes, improved ergonomics and ease of use.” The all-in-one Defend 1050 can be operated continuously around patients and staff to kill airborne pathogens, adsorb odours, neutralise volatile organic compounds (VOCs), and trap particulate as small as 0.12µm, he adds.

Although hand hygiene and surface cleaning are the norm in healthcare organisations, these have only limited effects due to low compliance and the ongoing presence of pathogens in the hospital environment, says McBrien. “The Defend 1050 is therefore a safe, continuous and effective air disinfection solution to augment hygiene protocols and reduce the transmission of infection in operating theatres, ICUs, hospital wards, emergency rooms, labs and other critical areas.”
 
Novaerus is taking advantage of its presence at the 2019 Arab Health Exhibition & Congress to re-enter the UAE market, following its relaunch in the country in October 2018.  “Arab Health is an important platform for us to extend our reach not only in the GCC region but also enter the rapidly growing markets of India and Africa. It also serves as a great opportunity to meet our distributors from both the GCC and other parts of the world.”

Arab Health, he adds, is a great venue to showcase new products and learn about innovations in other markets and product segments. “It is an exciting show, very well organized, and we always look forward to coming back.”

Keen on making a firm foothold in the region, Novaerus is supporting its partners in the MENA region by working with them in close cooperation in their respective markets. “These include making hospital visits, conducting training and seminars,” he concludes.